This biotech is a leader in the treatment of cystic fibrosis, and that’s helped earnings explode higher over the years. The ...

Outlining the key touchpoints for embracing change and opportunity in the “messy, tough—and fun” R&D-to-commercial transition ...

At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

The prospects of higher pay, regular hours, comprehensive benefits, and career growth has workers filling biotech training ...

During his tenure at Roche's Genentech, ophthalmologist Jason Ehrlich, M.D., Ph.D., supported the development of the ...

Aditum’s newly formed biotech, dubbed Kalexo Bio, will develop the asset for patients with elevated cholesterol, or dyslipidemia, and for the prevention of high-risk atherosclerotic cardiovascular ...

If you have been looking for Sector - Health funds, a place to start could be Franklin Biotechnology Discovery A (FBDIX). FBDIX carries a Zacks Mutual Fund Rank of 2 (Buy), which is based on various ...

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is one of the best affordable biotech stocks to invest in now . Rigel ...

A South San Francisco biotech startup has defied the industry's funding drought, securing a substantial investment for its ...

Talented people are losing their jobs, postdoctoral researchers are seeing contracts cut short and students are rushing to ...

Good morning. Today, former CDC officials will testify before the Senate health committee about the recent upheaval at the ...

From a small team of researchers and skipped salaries, CEO Michelle Xia has steered Akeso to become one of the most exciting ...